drugset / Trial / NCT00569387
Vaccine Study for Surgically Resected Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.
Timeline
- Start
- 2007-12
- Primary completion
- 2011-03
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Algenpantucel-L | Vaccine | 1e+08 cells | Intravenous |